| Literature DB >> 23110056 |
Ji Cheol Bae1, Sunghwan Suh, Se Eun Park, Eun Jung Rhee, Cheol Young Park, Ki Won Oh, Sung Woo Park, Sun Woo Kim, Kyu Yeon Hur, Jae Hyeon Kim, Myung-Shik Lee, Moon Kyu Lee, Kwang-Won Kim, Won-Young Lee.
Abstract
BACKGROUND: We evaluated the association of regular physical exercise with the presence of non-alcoholic fatty liver disease (NAFLD) and liver enzymes in relation to obesity and insulin resistance. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2012 PMID: 23110056 PMCID: PMC3478288 DOI: 10.1371/journal.pone.0046819
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Clinical characteristics based on the exercise regularity.
| Non-exercise | Exercise | All | ||
| (n = 59,392) | (n = 12,967) |
| (N = 72,359) | |
| Male (%) | 32,447 (54.6) | 6,507 (50.2) | <0.001 | 38,970 (53.8) |
| Age (years) | 41.3±8.3 | 45.2±8.9 | <0.001 | 42.0±8.5 |
| BMI (kg/m2) | 23.3±3.1 | 23.6±2.8 | <0.001 | 23.4±3.0 |
| Body fat (%) | 24.7±6.1 | 24.7±6.1 | 0.903 | 24.7±6.1 |
| Male | 21.7±4.8 | 21.1±4.5 | <0.001 | 21.5±4.7 |
| Female | 28.4±5.6 | 28.4±5.3 | 0.351 | 28.4±5.5 |
| Fasting glucose (mg/dl) | 93.1±8.7 | 93.3±9.1 | 0.082 | 93.1±8.5 |
| HbA1c (%) | 5.37±0.29 | 5.38±0.29 | <0.001 | 5.37±0.29 |
| HOMA-IR | 1.90±0.93 | 1.87±0.85 | <0.001 | 1.90±0.92 |
| Total-cholesterol (mg/dl) | 194.4±33.5 | 196.8±32.9 | <0.001 | 194.8±33.4 |
| Triglyceride (mg/dl) | 122.2±79.5 | 111.0±66.7 | <0.001 | 120.2±77.5 |
| LDL-C (mg/dl) | 110.5±29.3 | 110.7±28.6 | 0.436 | 110.6±29.2 |
| HDL-C (mg/dl) | 55.2±12.7 | 57.6±13.4 | <0.001 | 55.6±12.8 |
| Male | 50.6±10.6 | 52.6±11.2 | <0.001 | 50.9±10.9 |
| Female | 60.7±13.3 | 62.6±13.7 | <0.001 | 61.0±13.2 |
| Systolic BP (mmHg) | 112.8±13.6 | 114.5±14.2 | <0.001 | 113.1±13.7 |
| AST (unit/l) | 23.7±10.3 | 24.4±9.8 | <0.001 | 23.8±10.2 |
| ALT (unit/l) | 25.1±18.9 | 23.2±13.8 | <0.001 | 24.8±18.1 |
| Current smoking (%) | 12,909 (21.7) | 1,800 (13.9) | <0.001 | 14,709 (20.3) |
| NAFLD (%) | 16,873 (28.4) | 3,048 (23.5) | <0.001 | 19,921 (27.5) |
BMI, body mass index; HOMA-IR, homeostasis model assessment of insulin resistance; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; BP, blood pressure; AST, aspartate aminotransferase; ALT, alanine aminotransferase; NAFLD, non-alcoholic fatty liver disease.
Data are numbers (%) or means ± standard deviation.
By Pearson's χ2 –test.
By unpaired t –test.
The prevalence of NAFLD according to the exercise group and BMI deciles.
| BMI category | Non-exercise | Exercise | ||||
| (N = 72,359) | Non-NAFLD | NAFLD | n = 59,392 | Non-NAFLD | NAFLD | N = 12,967 |
| <19.6 (7,243) | 6,393 | 53 (0.8) | 6,446 | 788 | 9 (1.1) | 797 |
| 19.6–20.7 (7,284) | 5,919 | 201 (3.3) | 6,120 | 1,142 | 22 (1.9) | 1,164 |
| 20.7–21.6 (7,194) | 5,481 | 373 (6.4) | 5,854 | 1,268 | 72 (5.4) | 1,340 |
| 21.6–22.4 (7,291) | 5,183 | 711 (12.1) | 5,894 | 1,281 | 116 (8.3) | 1,397 |
| 22.4–23.2 (7,170) | 4,588 | 1,182 (20.5) | 5,770 | 1,228 | 172 (12.3) | 1,400 |
| 23.2–24.0 (7,247) | 4,263 | 1,579 (27.0) | 5,841 | 1,122 | 284 (20.2) | 1,406 |
| 24.0–24.8 (7,241) | 3,696 | 2,111 (36.4) | 5,807 | 1,038 | 396 (27.6) | 1,434 |
| 24.8–25.8 (7,267) | 3,069 | 2,745 (47.2) | 5,814 | 929 | 524 (36.1) | 1,453 |
| 25.8–27.8 (7,204) | 2,433 | 3,418 (58.4) | 5,851 | 716 | 637 (47.1) | 1,353 |
| ≥27.8 (7,218) | 1,494 | 4,501 (75.1) | 5,995 | 407 | 816 (66.7) | 1,223 |
NAFLD, non-alcoholic fatty liver disease; BMI, body mass index.
Data are numbers (%).
Figure 1The risk for NAFLD by exercise regularity analyzed separately according to the BMI deciles.
A) Adjusted for age and sex. B) Adjusted for age, sex, and body fat percentage. Odds ratios were estimated from binary logistic regression analysis.
Figure 2Association of metabolic risk factors with exercise regularity across the BMI level. Adjusted for age and sex.
Odds ratios for AST>41, ALT>38 IU according to the exercise regularity in subjects with NAFLD.
| NAFLD (n = 19,921) | |||
| Variables | Non-exercise | Exercise |
|
| Subjects, n | 16,873 | 3,048 | |
| Male, No. (%) | 13,573 (80.4) | 2,262 (74.2) | |
| Subjects with AST>41unit/l, No. (%) | 1,431 (8.5) | 192 (6.3) | |
| Subjects with ALT>38unit/l. No. (%) | 5,947 (35.2) | 737 (24.2) | |
| Adjusted odds ratio for AST >41 unit/l (95% CI) | |||
| Age and sex | 1 | 0.75 (0.64–0.88) | <0.001 |
| Age, sex, and body fat percentage | 1 | 0.80 (0.68–0.93) | 0.007 |
| Age, sex, body fat percentage, TG, LDL, HDL | 1 | 0.85 (0.74–0.99) | 0.042 |
| systolic BP, HOMA-IR, and smoking | |||
| Adjusted odds ratio for ALT >38 unit/l (95% CI) | |||
| Age and sex | 1 | 0.66 (0.61–0.73) | <0.001 |
| Age, sex, and body fat percentage | 1 | 0.70 (0.64–0.77) | <0.001 |
| Age, sex, body fat percentage, TG, LDL, HDL | 1 | 0.74 (0.67–0.81) | <0.001 |
| systolic BP, HOMA-IR, and smoking | |||
NAFLD, non-alcoholic fatty liver disease; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BP,
Blood pressure; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein.
Cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance.
Estimated by binary logistic regression analysis.